Spero Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- June 08, 2015
- Vertical
- Biopharmaceuticals
- Funding URL
- View Funding Page
- Funding Amount:
- $30,000,000
Company Info
- Founding Year
- 2015
- Founders
- Ankit Mahadevia
- Company Description
- Spero is a product-focused biopharmaceutical company developing a pipeline of novel treatments for bacterial infections, specifically targeting gram-negative bacterial infections. The company enhances existing drugs through its Spero Potentiator program and targets bacterial virulence and persistence with its MvfR inhibitor program.
- Market
- Bacterial Infections
- Location
- Cambridge, Massachusetts, USA
- Coinvestors
- Atlas Venture, Kraft Group, Lundbeckfond Ventures, Merck Research Labs Venture Fund, Partners Innovation Fund, SR One